VRTX

Vertex Pharmaceuticals Inc
Data: 2026-07-31
$477.1
Price
-0.95%
Change
$533.67
52W High
$362.50
52W Low

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Quick Stats
Jul 31, 2026

48.8

AI Score

HOLD

0.53

Volume Ratio

Aug 03, 2026

Next Earnings

16

+ve Days (30d)

14

-ve Days (30d)

VRTX Stock Summary

Last updated Jul 31, 2026

VRTX is currently trading at $477.1, positioned above its 200-day moving average of $452.92, indicating a long-term uptrend. The stock has a 52-week range of $362.5 to $533.67.

Technical Analysis: The 50-day moving average stands at $468.3, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 48.193, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.069, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates VRTX at 48.8/100 with a HOLD recommendation.

VRTX (Vertex Pharmaceuticals Inc) Indicators

Last updated Jul 31, 2026

Indicator Value
RSI(14) 48.193
CMF (20) -0.069
ROC (10) -1.761
ADX (14) 17.008
Indicator Value
MACD (12,26,9) 1.688
AROONOSC (14) -28.571
WILLAMS %R (14) -61.818
MFI (14) 41.503
VRTX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

VRTX Price vs Max Options Open Interest
VRTX Max Change In Options Open Interest

VRTX Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

VRTX Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

VRTX Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

VRTX Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Vertex Pharmaceuticals Inc is above both the 50 Day and 200 Day SMA which is considered Bullish.

VRTX Moving Averages Analysis

Vertex Pharmaceuticals Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 31, 2026

Vertex Pharmaceuticals Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 31, 2026

VRTX (Vertex Pharmaceuticals Inc) Simple Moving Averages

Moving Averages are last updated Jul 31, 2026

Days MA
10 479.7
20 486.73
30 486.35
50 468.3
100 456.01
200 452.92

VRTX Fundamental Analysis

P/E (Forward) 25.0627
P/E (Trailing) 28.6556
Market Cap ($) 122.3 billion
Earnings/Share ($) 16.81
Net Profit Margin (%) 0.3551
Dividend/Share ($) --
EPS Estimate Current Year ($) 18.9634
EPS Estimate Next Year ($) 21.3147
WallStreet Target Price ($) 554.91
Most Recent Quarter